Table 1 Demographics and clinical characteristics
Characteristics | Total (N = 41) | GMPP (N = 21) | CMPP (N = 20) | P |
|---|---|---|---|---|
Sex, n (%) | ||||
Male | 25 (61.0) | 10 (47.6) | 15 (75.0) | 0.072 |
Female | 16 (39.0) | 11 (52.4) | 5 (25.0) | |
Age, years | 7.0 ± 2.8 | 6.6 ± 2.9 | 7.3 ± 2.7 | 0.450 |
WBC(×109/L) | 9.7 ± 4.1 | 9.3 ± 3.5 | 10.1 ± 4.6 | 0.518 |
N% | 66.8 ± 11.9 | 60.2 ± 11.7 | 73.8 ± 7.5 | < 0.001 |
Hemoglobin (g/L) | 125.3 ± 11.2 | 126.0 ± 11.8 | 124.6 ± 10.8 | 0.705 |
Platelets (×109/L) | 292.3 ± 115.5 | 305.1 ± 144.7 | 278.9 ± 75.4 | 0.475 |
CRP (mg/L) | 10.0 (2.8–29.5) | 2.8 (2.8–12) | 15.0 (4.37–35.5) | 0.013 |
LDH (U/L) | 419.0 (301.3–604.5) | 313.5 (269.8–412.5) | 547.0 (420.0–684.0) | 0.001 |
ALT (U/L) | 18.0 (12.3–26.0) | 15.5 (10.5–18.8) | 20.0 (15.0–38.3) | 0.025 |
AST (U/L) | 32.5 (24.5–44.0) | 29.5 (23.3–36.0) | 40.0 (26.5–49.3) | 0.091 |
CK-MB (U/L) | 20.0 (16.3–25.8) | 20.0 (16.3–28.3) | 20.0 (16.5–24.8) | 0.892 |
PT (s) | 12.8 (11.9–13.9) | 12.1 (11.5–12.8) | 13.5 (12.6–14.2) | 0.001 |
APTT (s) | 31.3 (27.4–34.5) | 33.1 (29.7–34.9) | 28.2 (25.7–32.7) | 0.030 |
D-dimer (ng/ml) | 564.5 (163.5–1870.5) | 185.5 (116.0–548.8) | 1827.0 (635.8–2686.0) | < 0.001 |
Fibrinogen (g/L) | 3.7 (3.3–4.0) | 3.6 (3.3–3.7) | 3.7 (3.4–4.0) | 0.171 |
Parapneumonic effusion, n (%) | 18 (43.9) | 0 | 18 (90.0) | < 0.001 |
Necrotizing pneumonia, n (%) | 3 (7.3) | 0 | 3 (15.0) | 0.107 |
Respiratory failure, n (%) | 3 (7.3) | 0 | 3 (15.0) | 0.107 |
Total fever duration (d) | 9.0 (7.0–11.0) | 8.0 (7.0–10.0) | 10.0 (9.0–12.0) | 0.013 |
Length of hospital stays (d) | 10 (8.0–14.0) | 9.0 (7.0 − 12.0) | 12.5 (9.0–14.0) | 0.032 |
Hospitalization expenses (CNY) | 13,365.8 (11,714.9–17,107.33) | 11,916.4 (10,719.3–13,288.6) | 15,893.6 (14,231.0–25,034.4) | 0.001 |
Duration of disease at sampling (d) | 15.0 (13.0–18.0) | 16.0 (13.0–19.0) | 14.0 (13.0–17.0) | 0.206 |